Emery MS, Kovacs RJ (2018) Sudden cardiac death in athletes. JACC Heart Fail. https://doi.org/10.1016/j.jchf.2017.07.014
Thakkar K, Karajgi AR, Kallamvalappil AM, Avanthika C, Jhaveri S, Shandilya A, Anusheel, Al-masri R (2023) Sudden cardiac death in childhood hypertrophic cardiomyopathy. Dis Mon. https://doi.org/10.1016/j.disamonth.2023.101548
Baggish A, Wang F, Yared K, Kupperman E, Baggish AL, Hutter JAM, Weiner RB, Picard MH, Wood MJ (2010) Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Artic. Ann Intern Med. https://doi.org/10.1059/0003-4819-152-5-201003020-00004
Gati S, Sharma S, Pennell D (2018) The role of cardiovascular magnetic resonance imaging in the assessment of highly trained athletes. JACC Cardiovasc Imaging 11:247–259
Drezner JA, Sharma S, Baggish A, Papadakis M, Wilson MG, Prutkin JM, La Gerche A, Ackerman MJ, Borjesson M, Salerno JC (2017) International criteria for electrocardiographic interpretation in athletes: consensus statement. Br J Sports Med 51:704–731
Corrado D, Pelliccia A, Bjørnstad HH et al (2005) Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26:516–524
McClean G, Riding NR, Ardern CL, Farooq A, Pieles GE, Watt V, Adamuz C, George KP, Oxborough D, Wilson MG (2018) Electrical and structural adaptations of the paediatric athlete’s heart: a systematic review with meta-analysis. Br J Sports Med 52:230–230
Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP (2022) The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. Eur J Prev Cardiol 29(4):645–653. https://doi.org/10.1093/eurjpc/zwab046
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906. https://doi.org/10.1016/j.ijsu.2021.105906
Bramer WM, Rethlefsen ML, Kleijnen J, Franco OH (2017) Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Syst Rev. https://doi.org/10.1186/s13643-017-0644-y
Article PubMed PubMed Central Google Scholar
Higgins JP, Morgan RL, Rooney AA, Higgins JPT, Taylor KW, Thayer KA, Silva RA, Lemeris C, Akl EA, Bateson TF, Berkman ND, Glenn BS, Hróbjartsson A, LaKind JS, McAleenan A, Meerpohl JJ, Nachman RM, Obbagy JE, O’Connor A, Radke EG, Savović J, Schünemann HJ, Shea B, Tilling K, Verbeek J, Viswanathan M, Sterne JAC (2024) A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int 186:108602. https://doi.org/10.1016/j.envint.2024.108602
Article PubMed PubMed Central Google Scholar
Fernlund E, Liuba P, Carlson J, Platonov PG, Schlegel TT (2016) MYBPC3 hypertrophic cardiomyopathy can be detected by using advanced ECG in children and young adults. J Electrocardiol 49:392–400
Article CAS PubMed Google Scholar
Thompson AJ, Cannon BC, Wackel PL, Horner JM, Ackerman MJ, O’Leary PW, Eidem BW, Johnson JN (2016) Electrocardiographic abnormalities in elite high school athletes: comparison to adolescent hypertrophic cardiomyopathy. Br J Sports Med 50:105–110
Guerrier K, Anderson JB, Pratt J, King EC, Statile C, Wilmot I, Campbell M, Czosek RJ (2015) Correlation of precordial voltages to left ventricular mass on echocardiogram in adolescent patients with hypertrophic cardiomyopathy compared with that in adolescent athletes. Am J Cardiol 115:956–961
Fernlund E, Schlegel TT, Platonov PG, Carlson J, Carlsson M, Liuba P (2015) Peripheral microvascular function is altered in young individuals at risk for hypertrophic cardiomyopathy and correlates with myocardial diastolic function. Am J Physiol Heart Circ Physiol 308:H1351–H1358
Article CAS PubMed Google Scholar
Johnson JN, Horner JM, Ackerman MJ, Cannon BC, Eidem BW (2011) Assessing electrocardiographic screening in elite high school athletes with comparison to adolescents with hypertrophic cardiomyopathy. Circulation 124:A10616–A10616
Marshall M, Malik A, Shah M et al (2024) Patterns of electrocardiographic abnormalities in children with hypertrophic cardiomyopathy. Pediatr Cardiol 45:1692–1701
Lawley CM, Luczak-Wozniak K, Chung S-C, Field E, Barnes A, Starling L, Cervi E, Kaski JP (2024) Utility and acceptability of remote 6-lead electrocardiographic monitoring in children with inherited cardiac conditions. Arch Dis Child 109:742–747
Hauptmeijer RWL, Lippert L, Ten Cate FEAU, Fejzic Z, Leenders E, Wolf CM, Draaisma JMT (2024) Differentiating primary sarcomeric hypertrophic cardiomyopathy from Noonan syndrome: can the electrocardiogram be of use? Cardiol Young 34(3):597–603. https://doi.org/10.1017/S1047951123003177
Anvekar P, Stephens PJ, Calderon-Anyosa RJC, Kauffman HL, Burstein DS, Ritter AL, Ahrens-Nicklas RC, Vetter VL, Banerjee A (2024) Electrocardiographic findings in genotype-positive and non-sarcomeric children with definite hypertrophic cardiomyopathy and subclinical variant carriers. Pediatr Cardiol 45:1784–1797
Topriceanu C-C, Field E, Boleti O, Cervi E, Kaski JP, Norrish G (2023) Disopyramide is a safe and effective treatment for children with obstructive hypertrophic cardiomyopathy. Int J Cardiol 371:523–525
Tashiro N, Muneuchi J, Ezaki H, Kobayashi M, Yamada H, Sugitani Y, Watanabe M (2022) Ventricular repolarization dispersion is a potential risk for the development of life-threatening arrhythmia in children with hypertrophic cardiomyopathy. Pediatr Cardiol 43:1455–1461
Luczak-Wozniak K, Obsznajczyk K, Niszczota C, Werner B (2022) Electrocardiographic parameters associated with adverse outcomes in children with cardiomyopathies. J Clin Med. https://doi.org/10.3390/jcm11236930
Article PubMed PubMed Central Google Scholar
Yoshinaga M, Horigome H, Ayusawa M, Yasuda K, Kogaki S, Doi S, Tateno S, Ohta K, Hokosaki T, Nishihara E, Iwamoto M, Sumitomo N, Ushinohama H, Izumida N, Tauchi N, Kato Y, Kato T, Chisaka T, Higaki T, Yoneyama T, Abe K, Nozaki Y, Komori A, Kawai S, Ninomiya Y, Tanaka Y, Nuruki N, Sonoda M, Ueno K, Hazeki D, Nomura Y, Sato S, Hirono K, Hosokawa S, Takechi F, Ishikawa Y, Hata T, Ichida F, Ohno S, Makita N, Horie M, Matsushima S, Tsutsui H, Ogata H, Takahashi H, Nagashima M (2021) Electrocardiographic diagnosis of hypertrophic cardiomyopathy in the pre- and post-diagnostic phases in children and adolescents. Circ J 86(1):118–127. https://doi.org/10.1253/circj.CJ-21-0376
Tunca Sahin G, Ozgur S, Kafali HC, Sevinc Sengul F, Haydin S, Guzeltas A, Ergul Y (2021) Clinical characteristics of hypertrophic cardiomyopathy in children: an 8-year single center experience. Pediatr Int 63:37–45
Cortez D, Sharma N, Cavanaugh J, Tuozo F, Derk G, Lundberg E, Schlegel TT, Weiner K, Kiciman N, Alejos J, Landeck B, Aboulhosn J, Miyamoto S, Batra A, McCanta AC (2015) The spatial QRS-T angle outperforms the Italian and Seattle ECG-based criteria for detection of hypertrophic cardiomyopathy in pediatric patients. J Electrocardiol 48(5):826–833. https://doi.org/10.1016/j.jelectrocard.2015.07.016
Brothers MB, Oster ME, Ehrlich A, Strieper MJ, Mahle WT (2014) Novel electrocardiographic screening criterion for hypertrophic cardiomyopathy in children. Am J Cardiol 113:1246–1249
Martin AB, Garson AJ, Perry JC (1994) Prolonged QT interval in hypertrophic and dilated cardiomyopathy in children. Am Heart J 127:64–70
Article CAS PubMed Google Scholar
Guerrier K, Madueme PC, Jefferies JL, Anderson JB, Spar DS, Knilans TK, Czosek RJ (2016) Unexpectedly low left ventricular voltage on ECG in hypertrophic cardiomyopathy. Heart 102:292–297
Article CAS PubMed Google Scholar
Spicer RL, Rocchini AP, Crowley DC, Rosenthal A (1984) Chronic verapamil therapy in pediatric and young adult patients with hypertrophic cardiomyopathy. Am J Cardiol 53(11):1614-1619
Yetman AT, Hamilton RM, Benson LN, McCrindle BW (1998) Long-te
Comments (0)